|
|
|
Volumn 15, Issue 3 Suppl, 2009, Pages
|
|
The impact of residual CVD risk in the managed care setting.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
HYPOCHOLESTEROLEMIC AGENT;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NICOTINIC ACID;
SIMVASTATIN;
CARDIOVASCULAR DISEASE;
DRUG COMBINATION;
DRUG EFFECT;
ECONOMICS;
HEALTH INSURANCE;
HUMAN;
REVIEW;
RISK FACTOR;
STATISTICAL MODEL;
STATISTICS;
ANTICHOLESTEREMIC AGENTS;
ANTILIPEMIC AGENTS;
CARDIOVASCULAR DISEASES;
CHOLESTEROL, LDL;
DRUG THERAPY, COMBINATION;
HUMANS;
MANAGED CARE PROGRAMS;
MODELS, ECONOMIC;
NIACIN;
RISK FACTORS;
SIMVASTATIN;
|
|
EID: 69249206771
PISSN: None
EISSN: 19362692
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (4)
|
|
References (13)
|
